ESPE Abstracts (2018) 89 S6.1

Cardiomyocyte Glucocorticoid and Mineralocorticoid Receptors Antagonistically Regulate Heart Disease

Robert H Oakley, Diana Cruz-Topete, Bo He, Julie F Foley, Page H Myers, Monte S Willis, Celso E Gomez-Sanchez, Pierre Chambo & John A Cidlowski

NIEHS/NIH, Research Triangle Park, Durham, North Carolina, USA

Stress is increasingly associated with cardiac disease. Glucocorticoids are primary stress hormones that regulate homeostasis through two nuclear receptors, the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR). Cardiomyocytes express both receptors but little is known concerning their specific and coordinated actions in heart physiology and pathology. To examine the in vivo function of glucocorticoid signaling in the heart, we generated mice with cardiomyocyte-specific deletion of GR (cardioGRKO), MR (cardioMRKO), or both GR and MR (cardioGRMRdKO). The cardioGRKO mice spontaneously developed cardiac hypertrophy and left ventricular systolic dysfunction whereas the cardioMRKO mice exhibited normal heart function. Surprisingly, the cardioGRMRdKO mice were protected from cardiac disease. Gene expression profiling identified cardioprotective gene changes in the double knockout hearts that limit cardiac hypertrophy and promote cardiomyocyte survival. Re-installation of MR into the cardioGRMRdKO hearts reversed the cardioprotective gene changes and resulted in cardiac dysfunction. These findings demonstrate a deleterious role for cardiac MR signaling when unopposed by GR. Moreover, they reveal the target genes and cellular responses altered by MR that contribute to cardiac pathology. Therapies that shift the balance of cardiomyocyte glucocorticoid signaling to favor more GR and less MR activity may provide an improved approach for treating heart disease.

Article tools

My recent searches

No recent searches.